These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2931285)

  • 41. Serotonergic mechanisms and blood pressure in sheep.
    Nelson MA; Coghlan JP; Denton DA; Mills EH; Scoggins BA; Spence CD; Whitworth JA
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S117-9. PubMed ID: 2412029
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of indomethacin, renzapride, methysergide, ketanserin, granisetron and citalopram on serotonin-induced fluid accumulation in pig jejunum.
    Hansen MB; Thørboll JE; Beubler E; Skadhauge E
    Physiol Res; 1994; 43(2):83-93. PubMed ID: 7918343
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prolongation of rat tail bleeding time by ketanserin: mechanisms of action.
    Buczko W; Gambino MC; De Gaetano G
    Eur J Pharmacol; 1984 Aug; 103(3-4):261-8. PubMed ID: 6237923
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of ketanserin and DOI on spontaneous and 5-HT-evoked peristalsis of the pig ureter in vivo.
    Hauser DS; Mevissen M; Weiss R; Portier CJ; Scholtysik G; Studer UE; Danuser H
    Br J Pharmacol; 2002 Feb; 135(4):1026-32. PubMed ID: 11861331
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cardiovascular effects of ketanserin in closed-chest anesthetized dogs.
    van de Water A; Wouters L; Xhonneux R; Reneman S
    Arch Int Pharmacodyn Ther; 1985 Jun; 275(2):267-78. PubMed ID: 3161481
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of the antagonists MDL 72222 and ketanserin on responses of cat carotid body chemoreceptors to 5-hydroxytryptamine.
    Kirby GC; McQueen DS
    Br J Pharmacol; 1984 Sep; 83(1):259-69. PubMed ID: 6487893
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Peripheral 5-HT2-like receptors. Can they be classified with the available antagonists?
    Leff P; Martin GR
    Br J Pharmacol; 1986 Jul; 88(3):585-93. PubMed ID: 2943354
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 5-HT2-receptor antagonists: alpha 1- vs. 5-HT2-receptor blocking properties in blood vessels.
    Cohen ML; Schenck KW; Kurz KD
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S25-9. PubMed ID: 2459510
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Excitatory 5-hydroxytryptamine receptors in the cat urinary bladder are of the M- and 5-HT2-type.
    Saxena PR; Heiligers J; Mylecharane EJ; Tio R
    J Auton Pharmacol; 1985 Jun; 5(2):101-7. PubMed ID: 3160710
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of DOI, a putative 5-HT2 receptor agonist in the rat.
    Dabiré H; Chaouche-Teyara K; Cherqui C; Fournier B; Laubie M; Schmitt H
    Eur J Pharmacol; 1989 Sep; 168(3):369-74. PubMed ID: 2583242
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evidence that the putative 5-HT1A receptor agonists, 8-OH-DPAT and ipsapirone, have a central hypotensive action that differs from that of clonidine in anaesthetised cats.
    Ramage AG; Fozard JR
    Eur J Pharmacol; 1987 Jun; 138(2):179-91. PubMed ID: 2957220
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evidence that the novel antihypertensive agent, flesinoxan, causes differential sympathoinhibition and also increases vagal tone by a central action.
    Ramage AG; Wouters W; Bevan P
    Eur J Pharmacol; 1988 Jul; 151(3):373-9. PubMed ID: 3215269
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of a selective 5-HT2 antagonist, ketanserin, on the pulmonary responses to Escherichia coli endotoxin.
    Ball HA; Parratt JR; Rodger IW
    Br J Pharmacol; 1983 Oct; 80(2):295-301. PubMed ID: 6360280
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The specificity of ketanserin in the inhibition of serotonin-induced steroidogenesis in the rat adrenal zona glomerulosa.
    Williams BC; Shaikh S; Edwards CR
    J Hypertens Suppl; 1984 Dec; 2(3):S559-61. PubMed ID: 6100754
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Involvement of 5-HT2 receptors in the wet-dog shake behaviour induced by 5-hydroxytryptophan in the rat.
    Yap CY; Taylor DA
    Neuropharmacology; 1983 Jul; 22(7):801-4. PubMed ID: 6604883
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of yohimbine, WY 26392 and idazoxan on sympathetic nerve activity.
    Ramage AG; Tomlinson A
    Eur J Pharmacol; 1985 Feb; 109(2):153-60. PubMed ID: 2859996
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serotonin potentiates sympathetic responses evoked by spinal NMDA.
    Madden CJ; Morrison SF
    J Physiol; 2006 Dec; 577(Pt 2):525-37. PubMed ID: 16973701
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Specificity of the serotonergic antagonist ketanserin.
    Stott DJ; Robertson JI; Ball SG
    J Hypertens Suppl; 1985 Dec; 3(3):S191-3. PubMed ID: 2856702
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Receptors mediating the effects of 5-hydroxytryptamine on the tracheal vasculature and smooth muscle of sheep.
    Webber SE; Salonen RO; Widdicombe JG
    Br J Pharmacol; 1990 Jan; 99(1):21-6. PubMed ID: 2331572
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Responses of the systemic circulation and of the renin-angiotensin-aldosterone system to ketanserin at rest and exercise in normal man.
    Fagard R; Cattaert A; Lijnen P; Staessen J; Vanhees L; Moerman E; Amery A
    Clin Sci (Lond); 1984 Jan; 66(1):17-25. PubMed ID: 6690191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.